Session Information
2008 BIO International Convention
Click here to go to the previous page
New Therapeutic Modalities: Opportunities and Challenges
Track : Bench to Products
Program Code: 1384
Date: Tuesday, June 17, 2008
Time: 1:30 PM to 3:00 PM  EST
Location: 28CD
CHAIR (S):
Michael Taylor, CEO, Ensemble Discovery Corporation
Steve Wilton, PhD, Professor
SPEAKER (S):
Errol De Souza, PhD, President & CEO , Archemix Corporation
John Maraganore, PhD, CEO, Alnylam Pharmaceuticals, Inc
John Mendlein, PhD, Chief Executive Officer, Adnexus Therapeutics
Michael Taylor, CEO, Ensemble Discovery Corporation
Steve Wilton, PhD, Professor
Description
"The session will deal with novel emerging therapeutic modalities to address medical needs that cannot be met by existing therapeutic approaches. The opportunities to
complement some established modalities and the challenges
in building business around new therapeutic strategies will be discussed."
Objective 1: Understand the challenges in achieving the HHS Healthy People 2010 goals for immunization coverage.

Objective 2: Determine how to raise awareness of new immunization recommendations for adolescents.

Objective 3: Increase immunization rates among adolescents.


Streaming Audio with
PowerPoint Slides
(Code: 1384)
  
This session is a part of: